Abstract
We formulate a model that determines the net benefit of Johnes disease vaccination within a tuberculosis-accredited region given the extra costs associated with the vaccine-related cross-reactivity with tuberculosis test results and the probability of a tuberculosis outbreak. We apply the model to Minnesota and Michigan, where tuberculosis has recently become endemic. The expected benefit of Johnes vaccination of $53.03 per cow exceeds the cost of Johnes cross-reactivity of $32.72 and $32.42 per cow within each of the two Minnesota tuberculosis regions, as well as $31.99 and $30.78 per cow within each of the two Michigan tuberculosis regions.
| Original language | English |
|---|---|
| Pages (from-to) | 1446-1455 |
| Number of pages | 10 |
| Journal | American Journal of Agricultural Economics |
| Volume | 92 |
| Issue number | 5 |
| DOIs | |
| Publication status | Published - 1 Oct 2010 |
Funding
This project was funded by USDA-CSREES award number 2008-35204-04627 and the Johne’s Disease Integrated Program (JDIP, USDA) contract number 45105.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- bovine tuberculosis
- cross-reactivity
- dairy cattle disease
- Johnes disease
Fingerprint
Dive into the research topics of 'Economic analysis of the cross-reactivity of Johne's disease vaccination with tuberculosis in dairy cattle'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver